Medicis Pharma (MRX) Posts Q1 adj.-EPS of $0.54, Tops by 7c; Guides Q210 and FY10 EPS and Revs
Tweet Send to a Friend
Medicis Pharmaceutical Corp. (NYSE: MRX) reports Q1 adjusted EPS of $0.54, 7 cents better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
